134 related articles for article (PubMed ID: 34657877)
21. p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA).
Lv X; Ye G; Zhang X; Huang T
Medicine (Baltimore); 2017 Sep; 96(38):e8106. PubMed ID: 28930859
[TBL] [Abstract][Full Text] [Related]
22. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
[TBL] [Abstract][Full Text] [Related]
23. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma.
Shitani M; Sasaki S; Akutsu N; Takagi H; Suzuki H; Nojima M; Yamamoto H; Tokino T; Hirata K; Imai K; Toyota M; Shinomura Y
Tumour Biol; 2012 Oct; 33(5):1307-17. PubMed ID: 22457049
[TBL] [Abstract][Full Text] [Related]
25. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India.
Kiran M; Chawla YK; Kaur J
Cancer Genet Cytogenet; 2009 Dec; 195(2):112-9. PubMed ID: 19963110
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
[TBL] [Abstract][Full Text] [Related]
27. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
[TBL] [Abstract][Full Text] [Related]
28. Association of low p16INK4a and p15INK4b mRNAs expression with their CpG islands methylation with human hepatocellular carcinogenesis.
Qin Y; Liu JY; Li B; Sun ZL; Sun ZF
World J Gastroenterol; 2004 May; 10(9):1276-80. PubMed ID: 15112341
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma.
Sun S; Li Y; Han S; Jia H; Li X; Li X
BMC Med Genomics; 2019 Oct; 12(1):147. PubMed ID: 31660973
[TBL] [Abstract][Full Text] [Related]
30. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
[TBL] [Abstract][Full Text] [Related]
31. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
32. Is serum level of methylated RASSF1A valuable in diagnosing hepatocellular carcinoma in patients with chronic viral hepatitis C?
Mohamed NA; Swify EM; Amin NF; Soliman MM; Tag-Eldin LM; Elsherbiny NM
Arab J Gastroenterol; 2012 Sep; 13(3):111-5. PubMed ID: 23122451
[TBL] [Abstract][Full Text] [Related]
33. Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases.
Wei L; Huang Y; Zhao R; Zhang J; Liu Q; Liang W; Ding X; Gao B; Li B; Sun C; He J; Yu X; Liu Z; Sun A; Qin Y
Clin Exp Med; 2018 Feb; 18(1):79-87. PubMed ID: 28951980
[TBL] [Abstract][Full Text] [Related]
34. Studying the frequency of aberrant DNA methylation of APC, P14, and E-cadherin genes in HCV-related hepatocarcinogenesis.
Mekky MA; Salama RH; Abdel-Aal MF; Ghaliony MA; Zaky S
Cancer Biomark; 2018; 22(3):503-509. PubMed ID: 29865038
[TBL] [Abstract][Full Text] [Related]
35. Identification of TAF1, SAT1, and ARHGEF9 as DNA methylation biomarkers for hepatocellular carcinoma.
Cai C; Xie X; Zhou J; Fang X; Wang F; Wang M
J Cell Physiol; 2020 Jan; 235(1):611-618. PubMed ID: 31283007
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis.
Rongrui L; Na H; Zongfang L; Fanpu J; Shiwen J
Curr Pharm Des; 2014; 20(11):1715-25. PubMed ID: 23888939
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A.
Duong FH; Filipowicz M; Tripodi M; La Monica N; Heim MH
Gastroenterology; 2004 Jan; 126(1):263-77. PubMed ID: 14699505
[TBL] [Abstract][Full Text] [Related]
38. Methylation status of the T-cadherin gene promotor in peripheral blood mononuclear cells is associated with HBV-related hepatocellular carcinoma progression.
Yuan XD; Wang JW; Fang Y; Qian Y; Gao S; Fan YC; Wang K
Pathol Res Pract; 2020 May; 216(5):152914. PubMed ID: 32147273
[TBL] [Abstract][Full Text] [Related]
39. Hypermethylation of secreted frizzled related protein 2 gene promoter serves as a noninvasive biomarker for HBV-associated hepatocellular carcinoma.
Xiang L; Chen LM; Zhai YJ; Sun WJ; Yang JR; Fan YC; Wang K
Life Sci; 2021 Apr; 270():119061. PubMed ID: 33454364
[TBL] [Abstract][Full Text] [Related]
40. Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.
Di Gioia S; Bianchi P; Destro A; Grizzi F; Malesci A; Laghi L; Levrero M; Morabito A; Roncalli M
BMC Cancer; 2006 Apr; 6():89. PubMed ID: 16606445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
